ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation

BACKGROUND: Lung cancer is one of the most lethal malignant tumors that endangers human health. Lung adenocarcinoma (LUAD) has increased dramatically in recent decades, accounting for nearly 40% of all lung cancer cases. Increasing evidence points to the importance of the competitive endogenous RNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Bai-Quan, Lin, Xia-Hui, Lai, Song-Qing, Lu, Feng, Lin, Kun, Long, Xiang, Zhu, Shu-Qiang, Zou, Hua-Xi, Xu, Jian-Jun, Liu, Ji-Chun, Wu, Yong-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670189/
https://www.ncbi.nlm.nih.gov/pubmed/34906142
http://dx.doi.org/10.1186/s12935-021-02380-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670189/
https://www.ncbi.nlm.nih.gov/pubmed/34906142
http://dx.doi.org/10.1186/s12935-021-02380-2

Ejemplares similares